Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

Researchers found after bariatric procedures, patients lost an average of 58 pounds after two years, compared to 12 pounds ...

Type 2 diabetes patients taking semaglutide, often sold as Ozempic or Wegovy, have a slightly lower risk of stroke compared ...

Americans are sicker and shorter-lived than people in other rich countries. Here’s how to fix that. Health and Human Services ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could ...

Two companion papers out of Rutgers University — published June 14 in Nature Metabolism and Nature Communications—have traced ...

Semaglutide medications like Ozempic and Wegovy have shown proven results for managing conditions like type 2 diabetes and obesity. Also known as GLP-1 agonists, these drugs work by mimicking a ...

Denmark-based multinational pharmaceutical company Novo Nordisk will be making available in the Philippines within this year ...

Ultra-processed food has become public enemy number one, and plant-based meat has been caught in the crossfire. Here's ...

A new study found a link between GLP-1s and a higher risk of neovascular age-related macular degeneration, an eye disease ...

Dear Eric: I wanted to add a perspective to “Sad Aunt,” who felt great resentment at the nephews who were “gatekeepers” when ...